Clinical applications of induced sputum

Chest

Volumn 129, Issue 5, 2006, Pages 1344-1348

  Brightling, Christopher E ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Asthma; COPD; Cough; Sputum

Indexed keywords

CORTICOSTEROID;

ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; COUGHING; DIAGNOSTIC VALUE; HUMAN; HUMAN CELL; LUNG CANCER; LUNG TUBERCULOSIS; PRIORITY JOURNAL; REPRODUCIBILITY; RESPIRATORY TRACT DISEASE; REVIEW; SAMPLING; SPUTUM ANALYSIS; STANDARDIZATION; TECHNIQUE;

EID: 33646478111     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.129.5.1344     Document Type: Article

References (30)

1. Pavord ID, Pizzichini MM, Pizzichini E, et al. The use of induced sputum to investigate airway inflammation. Thorax 1997; 52:498-501
2. Recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children. Am J Respir Crit Care Med 1999; 160:2104-2117
3. Belda J, Leigh R, Parameswaran K, et al. Induced sputum cell counts in healthy adults. Am J Respir Crit Care Med 2000; 161(2 pt 1):475-478
4. Pizzichini E, Pizzichini MM, Leigh R, et al. Safety of sputum induction. Eur Respir J 2002; 20(37suppl):9S-18S
5. Efthimiadis A, Spanevello A, Hamid Q, et al. Methods of sputum processing for cell counts, immunocytochemistry and in situ hybridisation. Eur Respir J 2002; 20(37suppl):19S-23S
6. Green RH, Brightling CE, Woltmann G, et al. Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax 2002; 57:875-879
7. Hunter CJ, Brightling CE, Woltmann G, et al. A comparison of the validity of different diagnostic tests in adults with asthma. Chest 2002; 121:1051-1057
8. Girard F, Chaboillez S, Cartier A, et al. An effective strategy for diagnosing occupational asthma: use of induced sputum. Am J Respir Crit Care Med 2004; 170:845-850
9. Pavord ID, Brightling CE, Woltmann G, et al. Non-eosinophilic corticosteroid unresponsive asthma. Lancet 1999; 353:2213-2214
10. Gibson PG, Simpson JL, Saltos N. Heterogeneity of airway inflammation in persistent asthma: evidence of neutrophilic inflammation and increased sputum interleukin-8. Chest 2001; 119:1329-1336
11. Green RH, Brightling CE, McKenna S, et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 2002; 360:1715-1721
12. Bacci E, Cianchetti S, Bartoli M, et al. Low sputum eosinophils predict the lack of response to beclomethasone in symptomatic asthmatic patients. Chest 2006; 129:565-572
13. Little SA, Chalmers GW, MacLeod KJ, et al. Non-invasive markers of airway inflammation as predictors of oral steroid responsiveness in asthma. Thorax 2000; 55:232-234
14. Meijer RJ, Postma DS, Kauffman HF, et al. Accuracy of eosinophils and eosinophil cationic protein to predict steroid improvement in asthma. Clin Exp Allergy 2002; 32:1096-1103
15. Berry MA, Morgan A, Green RH, et al. Clinical and pathological features of non-eosinophilic asthma: a distinct asthma phenotype associated with inhaled corticosteroid resistance [abstract]. Thorax 2005; 60:ii4
16. Jayaram L, Pizzichini MM, Cook RJ, et al. Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations. Eur Respir J 2006; 27:483-494
17. Leuppi JD, Salome CM, Jenkins CR, et al. Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids. Am J Respir Crit Care Med 2001; 163:406-412
18. Jatakanon A, Lim S, Barnes PJ. Changes in sputum eosinophils predict loss of asthma control. Am J Respir Crit Care Med 2000; 161:64-72
19. Smith AD, Cowan JO, Brassett KP, et al. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 2005; 352:2163-2173
20. Pijnenburg MW, Bakker EM, Hop WC, et al. Titrating steroids on exhaled nitric oxide in children with asthma: a randomized controlled trial. Am J Respir Crit Care Med 2005; 172:831-836
21. 1 in smokers are associated with increased levels of sputum neutrophils. Thorax 1996; 51:267-271
22. Brightling CE, Monteiro W, Ward R, et al. Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 2000; 356:1480-1485
23. Pizzichini E, Pizzichini MM, Gibson P, et al. Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis. Am J Respir Crit Care Med 1998; 158(5 pt 1):1511-1517
24. Brightling CE, McKenna S, Hargadon B, et al. Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease. Thorax 2005; 60:193-198
25. Siva R, Green RH, Brightling CE, et al. Modulation of eosinophilic inflammation in COPD. Eur Respir J 2005; 26(Suppl 49):441s
26. Brightling CE, Ward R, Goh KL, et al. Eosinophilic bronchitis is an important cause of chronic cough. Am J Respir Crit Care Med 1999; 160:406-410
27. Brightling CE. Chronic cough due to nonasthmatic eosinophilic bronchitis: ACCP evidence-based clinical practice guidelines. Chest 2006; 129(suppl):116S-121S
28. Melvin R, Pratter MR, Brightling CE, et al. An empiric integrative approach to the management of cough: ACCP evidence-based clinical practice guidelines. Chest 2006; 129(1 suppl):222S-231S
29. Irwin RS. Chronic cough due to gastroesophageal reflux disease: ACCP evidence-based clinical practice guidelines. Chest 2006; 129(1 suppl):80S-894
30. Pizzichini MM, Pizzichini E, Parameswaran K, et al. Nonasthmatic chronic cough: no effect of treatment with an inhaled corticosteroid in patients without sputum eosinophilia. Can Respir J 1999; 6:323-330